BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 5, 2001
View Archived Issues
Maxim to conduct phase II trial of Ceplene in triple combination therapy for hepatitis C
Read More
Duke University initiates phase I telomerase immunotherapy trial for prostate cancer
Read More
Fatty acid-targeted taxane undergoing phase II testing for breast and prostate cancer
Read More
ISIS-3521-containing combinations effective, well tolerated in NSCLC according to phase I/II data
Read More
Novel apoptosis-inducing anticancer agent developed at NCI
Read More
FDA issues notice on use of doxycycline and penicillin G procaine in treatment of anthrax
Read More
CeNeS terminates opiate spray agreement with Bioglan
Read More
TBI-361, a new chemo- and radiosensitizing PARP inhibitor
Read More
Xolair BLA amendment will be submitted in the fourth quarter of 2002
Read More
ChemGenex investigates molecular targets of Ceflatonin
Read More
Year-end completion of recruitment expected in renal cell carcinoma trial of Neovastat
Read More
Completion of rolling BLA submission for Erbitux
Read More
Inhaled iseganan safe in cystic fibrosis patients
Read More
Next-generation oncolytic virus from Onyx selectively propagates in tumor cells
Read More
Favorable sixth phase III safety review of VaxGen's AIDS vaccine
Read More
Combination of GTI-2040 and capecitabine examined in renal cell carcinoma
Read More
New multidrug resistance modulator designed at Penn State
Read More
Neurocrine Biosciences highlights positive Q3 developments
Read More
Raf kinase inhibitor Bay-43-9006 advances through phase I trials without significant toxicity
Read More
Pharmacyclics offers update of products in advanced clinical trials
Read More
New agents for osteoporosis in the AxyS pipeline
Read More
Merck scientists identify peptidomimetic compounds for Alzheimer's disease
Read More
Preparation and use of 1,5-benzothiazepines that inhibit bile acid transport
Read More
Pyrimidinone-based GSK3beta inhibitors and uses described by Sanofi-Synthelabo
Read More
Dainippon synthesizes pyridonecarboxylic acid antibacterial agents
Read More
Kitastato team discovers FKI-0076, a naturally produced antifungal enhancer
Read More
SGLT2 inhibitors from Kissei useful for diabetes, obesity
Read More